Effects of neoadjuvant chemotherapy on MDR1 and MRP gene expression in primary breast cancer
β Scribed by Xing-e Liu; Xiao-dong Sun; Jin-min Wu
- Publisher
- Chinese Anti-Cancer Association
- Year
- 2004
- Tongue
- English
- Weight
- 375 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1000-9604
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Neoadjuvant chemotherapy in breast cancer was developed in the 1970s and is now used in patients with locally advanced or early resectable breast cancer. Early administration of systemic chemotherapy before local treatment in locally advanced breast cancer and early resectable breast cancer is inten
## Abstract The efficacy of breast cancer treatment is limited by the development of resistance to various chemotherapeutic agents. We conducted a retrospective study of the expression of 2 drug resistance efflux pumps, MRPβ1 and MDRβ1 Pgp, in 177 invasive breast carcinomas. Immunohistochemical exp
## Abstract For Abstract see ChemInform Abstract in Full Text.
The present study was undertaken to determine the pattern of expression of 2 molecular markers of multidrug resistance, the MDR-I and MRP genes, in endometrial carcinomas from 50 untreated patients using a PCR semi-quantitative assay. In addition, PCR analysis of MDR-I and MRP gene amplification was